Abstract:
Total laryngectomy, performed for advanced laryngeal carcinoma, results in loss of the vocal chords and a permanent neck stoma. To help restore speech various voice restoration methods – tracheoesophageal speech (TEP), electrolarynx and esophageal speech – are commonly employed. Whilst different methods exist however, TEP produces the best voice quality, is assumed to maximize patient quality of life and unsurprisingly is most commonly adopted by medical and health professionals. Although voice quality is clearly of importance however, each method is associated with varied costs and benefits that impact upon other areas related to quality of life in total laryngectomy patients. Following a discussion concerning the etiology, epidemiology and treatment for laryngeal carcinoma, this chapter reviews the literature related to health-related quality of life amongst total laryngectomy patients employing different voice restoration methods. It argues that, although important, voice quality alone does not determine quality of life following total laryngectomy. Consideration should therefore be given to the impact that each voice restoration method has upon all areas of quality of life, rather than focus upon voice quality alone. Implications of these conclusions for clinical practice are discussed at the end of the chapter.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- HNQOLQ:
-
University of Michigan head and neck quality of life questionnaire
- SF-36:
-
health specific quality of life measure
- TEP:
-
tracheoesphageal speech
References
Armstrong E, Isman K, Dooley P, Brine D, Riley N, Dentice R, King S, Khanhbai F. (2001). Head Neck. 23: 16–24.
Bjordal K, Ahlner-Elmqvist M, Tollesson E, Jensen AB, Razavi D, Maher EJ, Kaasa S. (1994). EORTC Quality of Life Study Group. 33: 879–885.
Blom ED. (1998). In: Blom ED, Singer M, Hamaker RC. (eds.) Trachesophageal Voice Restoration Following Total Laryngectomy. Singular, San Diego, pp. 1–8.
Blom ED. (2000). Oncology. 14: 915–922.
Clements KS, Rassekh CH, Seikaly H, Hokanson JA, Calhoun KH. (1997). Arch Otol Head Neck Surg. 123: 493–496.
Deleyiannis FW, Weymuller EA, Coltrera MD. Furtran N. (1999). Head Neck. 21: 319–324.
DeSanto LW, Olsen KD, Perry WC, Rohe DE, Keith RL. (1995). Ann Oto Rhinol Laryn. 104: 763–769.
Devlin JG, Langer CJ. (2007). Expert Rev Anticanc. 7: 331–350.
Drummond S, Dancer J, Krueger K, Spring G. (1996). Percept Motor Skill. 83: 801–802.
Eadie TL, Doyle PC. (2004). Laryngoscope. 114: 753–759.
Farrand P, Duncan F. (2007). Psychol Health Med. 12: 255–265.
Ferrer Ramírez MJ, Guallart Doménech F, Brotons Durbán S, Carrasco Llatas M, Estellés Ferriol E, López Martínez R. (2001). Eur Arch Oto-Rhino-L. 258: 463–466.
Finizia MD, Bergman B. (2001). Laryngoscope. 111: 918–923.
Finizia C, Hammerlid E, Westin T, Lindström J. (1998a). Laryngoscope. 108: 1566–1573.
Finizia C, Lindström J, Dotevall H. (1998b). Laryngoscope. 108: 138–143.
Forastiere AA, Trotti A, Pfister DG, Grandis JR. (2006). J Clin Oncol. 24: 2603–2605.
Funk GF, Karnell LH, Christensen AJ, Moran PJ, Ricks J. (2003). Head Neck. 25: 561–575.
Hall FT, O’Brien CJ, Clifford AR, McNeil EB, Bron L, Jackson MA. (2003). ANZ J Surg. 73: 300–305.
Harwood AR, Rawlinson E. (1983). Int J Radiat Oncol. 9: 335–338.
Herranz J, Sarandeses A, Fernández MF, Barro CV, Vidal JM, Gavilán J. (2000). Otolaryng Head Neck. 122: 892–898.
Hilgers FJM, Ackerstaff AH, Aaronson NK, Schouwenburg PF, Van Zandwijk N. (1990). Clin Otolaryngol. 15: 421–425.
Hoffman HT, Porter K, Karnell LH, Cooper JS, Weber RS, Langer CJ, Ang KK, Gay G, Stewart A, Robinson R. (2006). Laryngoscope. 116 (Suppl. 2): 1–13.
Janse AJ, Gemke RJ, Uiterwaal CSPM, Tweel I, van der Kimpen JL, Sinnema G. (2004). J Clin Epidemiol. 57: 653–661.
Jenkinson C, Coulter A, Wright L. (1993). British Med J. 306: 1437–1440.
List MA, D’Antonio LL, Cella DF, Siston A, Mumby P, Haraf D, Vokes E. (1996a). Cancer. 77: 2294–2301.
List MA, Ritter-Sterr CA, Baker TM, Colangelo LA, Matz G, Roa Pauloski B, Logemann JA. (1996b). Head Neck. 18: 1–10.
LoTempio MM, Wang KH, Sadeghi A, Delacure MD, Juillard GF, Wang MB. (2005). Otolaryng Head Neck. 132: 948–953.
Marioni G, Marchese-Ragona R, Giuseppe Cartei G, Fortunata Marchese F, Staffieri A. (2006). Cancer Treat Rev. 32: 504–515.
McNeil BJ, Weichselbaum R, Pauker SG. (1981). New Engl J Med. 305: 982–987.
Mohide EA, Archibald SD, Tew M, Young JE. (1992). Am J Surg. 14: 619–622.
Morris HL, Smith AE, Van Demark DR, Maves MD. (1992). Ann Oto Rhinol Laryn. 101: 503–510.
Morton RP, Witterick IJ. (1995). Am J Otolaryngol. 16: 284–293.
Office for National Statistics. (2007). Cancer Registration Statistics 2004. The Stationary Office, London.
Otto RA, Dobie RA, Lawrence V, Sakai C. (1997). Ann Oto Rhinol Laryn. 106: 693–699.
Paydarfar JA, Birkmeyer NJ. (2006). Arch Otolaryngol. 132: 67–72.
Pillon J, Gonçalves MIR, De Biase NG. (2004). Sao Paulo Med J. 122: 195–199.
Pou AM. (2004). Otolaryng Clin N Am. 37: 507–517.
Pusic A, Liu JC, Chen CM, Cano S, Davidge K, Klassen A, Branski R, Patel S, Kraus D, Cordeiro PG. (2007). Otolaryng Head Neck.136: 525–535.
Risberg-Berlin B, Möller RY, Finizia C. (2007). Arch Otolaryngol. 133: 650–654.
Robbins J, Fisher HB, Blom EC, Singer MI. (1984). J Speech Hear Disord. 49: 202–210.
Rogers SN, Lowe D, Brown JS. (1999). Head Neck. 21: 394–401.
Schuster M, Toy H, Lohscheller J, Eysholdt U, Rosanowski F. (2003). Folia Phoniatr Logo. 55: 211–219.
Sinkiewicz A, Winiarski P, Mackiewicz H, Owczarzak H, Janicka-Beutch L, Betlejewski S. (2006). Otolaryngol Pol. 60: 33–36.
Stewart MG, Chen AY, Stach CB. (1998). Arch Otolaryngol. 124: 143–148.
Taylor JC, Terrell JE, Ronis DL, Fowler KE, Bishop C, Lambert MT, Myers LL, Duffy SA. (2004). The University of Michigan Head and Neck Cancer Team. Arch Otolaryngol. 130: 764–769.
Terrell JE, Fisher SG, Wolf MD. (1998). Arch Otolaryngol. 124: 964–971.
Terrell JE, Nanavati KA, Esclamado RM, Bishop JK, Bradford CR, Wolf GT. (1997). Arch Otolaryngol Head Neck Surg. 123: 1125–1132.
Ward EC, Bishop B, Frisby J, Stevens M. (2002). Arch Otolaryngol. 128: 181–186.
Williams SE, Watson JB. (1987). Laryngoscope. 97: 737–739.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media LLC
About this entry
Cite this entry
Farrand, P., Endacott, R. (2010). Speech Determines Quality of Life Following Total Laryngectomy: The Emperors New Voice?. In: Preedy, V.R., Watson, R.R. (eds) Handbook of Disease Burdens and Quality of Life Measures. Springer, New York, NY. https://doi.org/10.1007/978-0-387-78665-0_117
Download citation
DOI: https://doi.org/10.1007/978-0-387-78665-0_117
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-78664-3
Online ISBN: 978-0-387-78665-0
eBook Packages: MedicineReference Module Medicine